期刊文献+

非酒精性脂肪肝活组织检查的抽样变异性 被引量:16

Sampling variability of liver biopsy in nonalcoholic fatty liver disease
下载PDF
导出
摘要 Background &Aims: In nonalcoholic fatty liver disease (NAFLD), the distinction between steatosis and steatohepatitis (NASH) and the assessment of the severity of the disease rely on liver histology alone. The aim of this study was to assess the sampling error of liver biopsy and its impact on the diagnosis and staging of NASH. Methods: Fifty-one patients with NAFLD underwent percutaneous liver biopsy with 2 samples collected. The agreement between paired biopsy specimens was assessed by the percentage of discordant results and by the κreliability test. Results: No features displayed high agreement; substantial agreement was only seen for steatosis grade; moderate agreement for hepatocyte ballooning and perisinusoidal fibrosis; fair agreement for Mallory bodies; acidophilic bodies and lobular inflammation displayed only slight agreement. Overall, the discordance rate for the presence of hepatocyte ballooning was 18%, and ballooning would have been missed in 24%of patients had only 1 biopsy been performed. The negative predictive value of a single biopsy for the diagnosis of NASH was at best 0.74. Discordance of 1 stage or more was 41%. Six of 17 patients with bridging fibrosis (35%) on 1 sample had only mild or no fibrosis on the other and therefore could have been under staged with only 1 biopsy. Intraobserver variability was systematically lower than sampling variability and therefore could not account for most of the sampling error. Conclusions: Histologic lesions of NASH are unevenly distributed throughout the liver parenchyma; therefore, sampling error of liver biopsy can result in substantial misdiagnosis and staging inaccuracies. Background &Aims: In nonalcoholic fatty liver disease (NAFLD), the distinction between steatosis and steatohepatitis (NASH) and the assessment of the severity of the disease rely on liver histology alone. The aim of this study was to assess the sampling error of liver biopsy and its impact on the diagnosis and staging of NASH. Methods: Fifty-one patients with NAFLD underwent percutaneous liver biopsy with 2 samples collected. The agreement between paired biopsy specimens was assessed by the percentage of discordant results and by the κreliability test. Results: No features displayed high agreement; substantial agreement was only seen for steatosis grade; moderate agreement for hepatocyte ballooning and perisinusoidal fibrosis; fair agreement for Mallory bodies; acidophilic bodies and lobular inflammation displayed only slight agreement. Overall, the discordance rate for the presence of hepatocyte ballooning was 18%, and ballooning would have been missed in 24%of patients had only 1 biopsy been performed. The negative predictive value of a single biopsy for the diagnosis of NASH was at best 0.74. Discordance of 1 stage or more was 41%. Six of 17 patients with bridging fibrosis (35%) on 1 sample had only mild or no fibrosis on the other and therefore could have been under staged with only 1 biopsy. Intraobserver variability was systematically lower than sampling variability and therefore could not account for most of the sampling error. Conclusions: Histologic lesions of NASH are unevenly distributed throughout the liver parenchyma; therefore, sampling error of liver biopsy can result in substantial misdiagnosis and staging inaccuracies.
出处 《世界核心医学期刊文摘(胃肠病学分册)》 2005年第10期29-30,共2页 Core Journals in Gastroenterology
  • 相关文献

同被引文献91

  • 1Sital Singh,Gabriela N.Kuftinec,Souvik Sarkar.Non-alcoholic Fatty Liver Disease in South Asians:A Review of the Literature[J].Journal of Clinical and Translational Hepatology,2017,5(1):76-81. 被引量:16
  • 2许嘉,巴蕾,吴文仓,李勇.脂肪肝的流行病学研究进展[J].慢性病学杂志,2013,13(7):539-542. 被引量:46
  • 3Shira Zelber-Sagi,Muriel Webb,Nimer Assy,Laurie Blendis,Hanny Yeshua,Moshe Leshno,Vlad Ratziu,Zamir Halpern,Ran Oren,Erwin Santo.Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification[J].World Journal of Gastroenterology,2013,19(1):57-64. 被引量:9
  • 4Shiro Yokohama,Yoshihiko Tokusashi,Kimihide Nakamura,Yosui Tamaki,Satoshi Okamoto,Mituyoshi Okada,Kazunobu Aso,Takenao Hasegawa,Masaru Aoshima,Naoyuki Miyokawa,Masakazu Haneda,Masashi Yoneda.Inhibitory effect of angiotensinⅡreceptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis[J].World Journal of Gastroenterology,2006,12(2):322-326. 被引量:10
  • 5Jaskiewicz K.,Raczynska S.,Rzepko R.,Sledziński Z,纪泛扑.胃成形术治疗肥胖者的非酒精性脂肪性肝病[J].世界核心医学期刊文摘(胃肠病学分册),2006,2(6):4-5. 被引量:1
  • 6John B Dixon MBBS, PhD, FRACGP,Prithi S Bhathal MBBS, PhD, FRCPA,Paul E O’Brien MD, FRACS.Weight Loss and Non-alcoholic Fatty Liver Disease: Falls In Gamma-Glutamyl Transferase Concentrations are Associated with Histologic Improvement[J].Obesity Surgery.2006(10)
  • 7K. Jaskiewicz MD,S. Raczynska,R. Rzepko,Z. Sledziński.Nonalcoholic Fatty Liver Disease Treated by Gastroplasty[J].Digestive Diseases and Sciences.2006(1)
  • 8Charalabos Stratopoulos MD,Alexandros Papakonstantinou MD,Ioannis Terzis MD,Charis Spiliadi MD,George Dimitriades MD, PhD,Vasiliki Komesidou,Panagiota Kitsanta MD,Theodoros Argyrakos MD,Evagelos Hadjiyannakis MD, PhD.Changes in Liver Histology Accompanying Massive Weight Loss after Gastroplasty for Morbid Obesity[J].Obesity Surgery.2005(8)
  • 9Keishi Kanno MD,Susumu Tazuma MD,Tomoji Nishioka MD,Hideyuki Hyogo MD,Kazuaki Chayama MD.Angiotensin II Participates in Hepatic Inflammation and Fibrosis through MCP-1 Expression[J].Digestive Diseases and Sciences.2005(5)
  • 10Yao Hong Wei,Li Jun,Chen Ji Qiang.Effect of Losartan, an Angiotensin II Antagonist, on Hepatic Fibrosis Induced by CCl4 in Rats[J].Digestive Diseases and Sciences.2004(10)

引证文献16

二级引证文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部